Report : Structural Heart Market to 2025 - Global Analysis and Forecasts By Product (Occluders, Annuloplasty Rings, Heart Valve Balloons, and Others) By Procedure (Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Mitral Repair and Left Atrial Appendage Closure); By End User (Hospitals, Ambulatory Surgical Centers and Cardiac Centers) and Geography
Occluders Are Likely To Drive The Market For Structural Heart In The Coming Forecasted Period 2018-2025
According to a new market research study titled ‘Structural Heart Market to 2025 - Global Analysis and Forecasts by Product, Procedure and End User, the global structural heart market was valued at US$ 6,406.3 Mn in 2017 and is estimated to reach US$ 13,850.2Mn by 2025. The report highlights the trends prevalent in the global structural heart market and the factors driving the market along with the restraints that are impacting its growth.
The product segment is divided into occluders, annuloplasty rings, heart valve balloon and others. Among the product segment the occluders holds the largest market share whereas, the heart valve balloons is the fastest growing segment. The dominancy is expected to be continued by the occluders due to the advantages offered such as it reduces 50% of the meshwork material on the left atrial side and eliminates the left atrial disc microsrew it minimizes the risk of thrombus formation and damage to the distal wall of the left atrium during the implantation procedure. Also the delivery cable mechanism varies and it allows pivoting of the devices, it also have features fir the large defects and borderline length. Moreover, the devices are fully repositionable and recapturable. The market for structural heart by the product segment is expected to reach US$ 13,850.2 million by 2025 in the forecasted period. Occluders segment has the highest market share in 2017, contributing a market share of 42.0% and is expected to retain its dominance during the forecast period from 2018 to 2025 to account for a market share of 42.5% of the overall revenue generated in 2025.
The report includes the driving factors such as innovative structural heart services, clinical trials, rise in the number of cardiovascular procedure and corresponding training programs and changing lifestyle increasing disease burden. The growth opportunities in the emerging market is likely to open up additional opportunities for the market growth in coming near future. Similarly, the trend that is expected to drive the growth of the market in coming future is technological advancement.
Key industry players operating in the field of structural heart across the globe include Abbott, Medtronic, Boston Scientific Corporation, CryoLife Ins, Edwards Lifesciences Corporation, LivaNova Plc, Lepu Medical, Braile Biomedica, Labcor Laboratorios Ltda, Aran biomedical Teornta among others.
The report segments the global structural heart market as follows:
Global Structural Heart Market - By Product
Heart Valve Balloons
Global Structural Heart Market - By Procedure
Surgical Aortic Valve Replacement
Transcatheter Aortic Valve Replacement
Left Atrial Appendage Closure
Global Structural Heart Market - By End User
Ambulatory Surgical Centers
Global Structural Heart Market - By Geography
Asia Pacific (APAC)
Middle East & Africa (MEA)
South & Central America (SCAM)
Contact Person: Sameer Joshi
Email Id: email@example.com